NAB, CBS Join Coalition Opposing Pharmaceutical Ad Restrictions
June 6, 2007 at 4:53 PM (PT)
The NAB, CBS, and NBC have joined several advertising, newspaper, and magazine associations in a group opposing H.R. 1561, the Enhancing Drug Safety and Innovation Act of 2007, which would ban advertising of new medications for three years, require pre-clearance of pharmaceutical ads by the FDA, mandate warnings for unspecified and unidentified risks, and require warning symbols in ads for new medications.
The ADVERTISING COALITION, which also includes the AMERICAN ADVERTISING FEDERATION, the AMERICAN ASSOCIATION OF ADVERTISING AGENCIES, the ASSOCIATION OF NATIONAL ADVERTISERS, the MAGAZINE PUBLISHERS OF AMERICA, the NCTA, the NATIONAL NEWSPAPER ASSOCIATION, and the NEWSPAPER ASSOCIATION OF AMERICA, sent a letter today (6/6) to members of the House Energy and Commerce Committee opposing the bill as unconstitutional and suggesting "replacing the unconstitutional provisions with a new process to assure that advertising monitored by the [FDA] is truthful and not misleading," specifically giving the FDA the power to fine pharmaceutical companies for false advertising.